Skip to content
A message from Michel Sadelain, MD, PhD, Director of the Columbia Initiative in Cell Engineering and Therapy (CICET) at VP&S.
CICET’s GMP Facility advances cell and gene therapies with clean rooms, FDA standards, and quality systems to support safe early trials.
